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Objective 1 
Lateral wedge insoles are intended to reduce biomechanical risk factors of medial knee 2 
osteoarthritis (OA) progression, such as increased knee joint load; however, there has been no 3 
definitive consensus on this topic. The aim of this systematic review and meta-analysis was 4 
to establish the within-subject effects of lateral wedge insoles on knee joint load in people 5 
with medial knee OA during walking. 6 
Methods 7 
Six databases were searched from inception until February 13th 2015. Included studies 8 
reported on the acute biomechanical effects of lateral wedge insoles in people with medial 9 
knee osteoarthritis during walking. Primary outcomes of interest relating to the 10 
biomechanical risk of disease progression were the 1st and 2nd peak external knee adduction 11 
moment (EKAM) and knee adduction angular impulse (KAAI). Eligible studies were pooled 12 
using random-effects meta-analysis. 13 
Results 14 
Eighteen studies were included with a total of 534 participants. Lateral wedge insoles resulted 15 
in a small but statistically significant reduction in the 1st peak EKAM (SMD: -0.19; 95% CI -16 
0.23 − -0.15) and 2nd peak EKAM (SMD: -0.25; 95% CI -0.32 − -0.19) with a low level of 17 
heterogeneity (I2 = 5% and 30%, respectively). There was a favourable but small reduction in 18 
the KAAI with lateral wedge insoles (SMD: -0.14; 95% CI -0.21 − -0.07, I2 =31%). Risk of 19 
methodological bias scores (Quality Index) ranged from 8 to 13 out of 16. 20 
Conclusions 21 
Lateral wedge insoles cause small reductions in the EKAM and KAAI in people with medial 22 
knee OA during walking. At present, they appear ineffective at attenuating structural changes 23 
in people with medial knee OA as a whole and may be better suited to targeted use in 24 
biomechanical phenotypes associated with larger reductions in knee load. 25 
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Systematic Review Registration (PROSPERO): CRD42015015392 26 
 27 
Significance and Innovations 28 
 This review presents the first comprehensive synthesis of studies investigating the 29 
effect of lateral wedge insoles on biomechanical risk factors for medial knee 30 
osteoarthritis progression, such as medial knee joint loading  31 
 This review of 18 studies found lateral wedge insoles had a small statistically 32 
significant effect on reducing the 1st and 2nd peak external knee adduction moment 33 
and knee adduction angular impulse 34 
 Biomechanical effects of lateral wedge insoles persisted regardless of whether a sham 35 
insole or footwear was used as the comparison condition  36 
 Variability in patient response highlights the need to consider the potential of lateral 37 
wedge insoles to attenuate disease progression in specific biomechanical phenotypes 38 
 39 
 40 
 41 
 42 
 43 
 44 
 45 
 46 
 47 
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The local mechanical environment plays an important role in the pathogenesis of knee 48 
osteoarthritis (OA) (1). Knee joint loading, estimated using surrogate measures such as the 49 
external knee adduction moment (EKAM), has been implicated in both the development of 50 
knee pain and radiographic progression of medial knee OA in older adults (2, 3). Knee load 51 
during walking is also positively associated with levels of subchondral bone change (4), 52 
worsening of bone marrow lesions (5), cartilage loss (6) and progression to total knee 53 
replacement in those with established disease (7). Non-invasive interventions aimed at 54 
reducing knee load during walking may therefore hold potential to slow disease progression 55 
in people with medial knee OA.    56 
The medial knee compartment more commonly shows radiographic disease, proposed to be a 57 
result of bearing a greater proportion of load (~60%) compared to the lateral compartment 58 
(~40%) during walking (8). The EKAM has been used as a proxy for medial knee joint load 59 
and a reduction in the EKAM represents a change in medial to lateral distribution and a 60 
relative lowering of the medial compartment load (9). The area underneath the EKAM curve, 61 
the knee adduction angular impulse (KAAI), represents the cumulative effect of the EKAM 62 
over the stance phase (10). High medial knee loading during walking estimated using the 63 
EKAM and KAAI is predictive of structural progression in knee OA (3, 6, 11), and as they 64 
are modifiable factors with conservative interventions, are potential targets to slow disease 65 
progression.   66 
Lateral wedge insoles are in-shoe devices that lower medial tibiofemoral compartment load to 67 
potentially reduce the deleterious effects of aberrant mechanics in knee OA. Originally 68 
described in 1987 by Yasuda & Sasaki (12), they consist of a simple wedged insole with an 69 
elevated lateral profile and angle of inclination facing toward the outside of the heel. 70 
Variations to this design have been described, ranging from shortened devices covering only 71 
the heel (13), to modifications of over-the-counter arch supports (14).The elevated lateral 72 
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profile of lateral wedge insoles shifts the point of application of the ground reaction force 73 
(centre of pressure) toward the outside of the foot, shortening the ground reaction force lever 74 
arm on the inside of the knee and reducing the EKAM (15).  75 
The clinical and biomechanical effects of lateral wedge insoles in people with medial knee 76 
OA have been extensively studied. Recommendations feature in clinical guidelines for the 77 
conservative management of knee OA, including those from the American College of 78 
Rheumatology (ACR) (16) and Osteoarthritis Society International (OARSI) (17). However, 79 
recommendations remain inconsistent. Internationally, some guidelines issue a conditional 80 
recommendation (16, 17), whilst others do not recommend use of lateral wedge insoles on the 81 
basis of equivocal evidence of any benefit on pain or knee function (18). A recent meta-82 
analysis demonstrated an effect of lateral wedge insoles on pain outcomes below the 83 
minimally clinical important difference for OA (19). However, to our knowledge, there 84 
remains no comprehensive meta-analysis of their effect on biomechanical risk factors for 85 
knee OA progression, such as knee load. The objective of this review was to determine the 86 
within-subject effects of lateral wedge insoles on biomechanical risk factors for disease 87 
progression (EKAM and KAAI) in patients with medial knee OA during walking.  88 
Methods 89 
Design 90 
This systematic review was conducted in accordance with the Preferred Reporting Items for 91 
Systematic Reviews and Meta-Analyses (PRISMA) Statement guidelines (20). This protocol 92 
for this review was registered on the international prospective register of systematic reviews 93 
(PROSPERO), registration number (CRD42015015392).  94 
Search Strategy 95 
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The PICO (Population, Intervention, Comparison and Outcome) framework was used to 96 
define the search strategy. The electronic databases Medline (via OvidSP), EMBASE (via 97 
OvidSP), CINAHL (via EBSCOhost), AMED (via OvidSP), Scopus and Web of Science (via 98 
ISI Web of Knowledge) were searched from inception to February 13th 2015. Searches were 99 
limited to studies on adults aged ≥18 years published in English. The Medical Subject 100 
Headings (MeSH) were used for keywords where available, with an example of the full 101 
search terms and combinations provided in Supplementary File 1. Search terms included a 102 
mixture of words relating to gait kinetics, kinematics and muscle activity to maximise the 103 
chance of retrieving relevant studies as these outcomes are frequently reported together. Each 104 
database was searched by two independent researchers to ensure reproducibility, with 105 
agreement required on the number of search hits achieved in each database before screening 106 
was initiated. 107 
Eligibility Criteria 108 
To be included in this review, studies must have been peer-reviewed journal articles 109 
investigating the biomechanical effects of laterally wedged insoles in adults with knee 110 
osteoarthritis during walking. All study designs were considered, as long as they included a 111 
within-group comparison of baseline versus insole conditions in people with medial knee 112 
OA. Eligible designs included (but were not limited to): randomised controlled trials (RCTs), 113 
Quasi-RCTs, non-RCTs, cohort studies, case-control and case-series. Systematic and 114 
narrative reviews were eligible for the purposes of manual reference list searching only to 115 
identify any studies missed in the primary search. Conference abstracts and unpublished data 116 
were not eligible. 117 
Studies must have investigated a lateral wedged insole, defined as an in-shoe orthotic device 118 
with an angle of inclination towards the lateral border of the foot. No restrictions were made 119 
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regarding the features of insoles (i.e. length – heel or full-length), degree of angulation, 120 
density or presence of concurrent arch support in the device. For prospective studies, only 121 
baseline data inferring the immediate effects of lateral wedge insoles were used. Studies 122 
allowing greater than a one month wear-in period were excluded, as this is the longest time 123 
period where effects are shown not to decline with continued wear (21).  124 
As this review was focused on the biomechanical effects specific to lateral wedge insoles, 125 
studies must have included a comparison condition where the insole was not used during 126 
walking. This could be either in the same footwear but with the insole removed or in the same 127 
footwear with a sham device (thin flat insole) that is theoretically biomechanically ‘inert’ 128 
relative to the laterally wedged insole. This allowed the type of footwear, which can itself 129 
independently alter knee biomechanics, to be controlled within studies. Studies testing 130 
‘variables stiffness’ shoes, were not eligible as although these devices work by the same 131 
mechanism, other design features may impact upon their effects and it is unclear if shoe 132 
features could be held constant across testing conditions (22, 23). Primary outcome variables 133 
of interest were specific due to their relevance to disease progression included features of the 134 
external knee adduction moment; the 1st peak EKAM, 2nd peak EKAM and the area under the 135 
EKAM curve, the knee adduction angular impulse (KAAI).  136 
Study inclusion 137 
All articles from searching of electronic databases were aggregated in bibliographic software 138 
(Endnote® X7, Thomson Reuters, Philadelphia, USA), where duplicate references were 139 
removed and cross-checked between two researchers to ensure agreement. The eligibility 140 
criteria were applied to the title and abstract by two independent researchers, with the 141 
retained articles again cross-checked. The retained articles were retrieved in full-text and 142 
screened according to the criteria, with the final remaining articles forming the results of the 143 
8 
 
systematic review. Discrepancies in eligibility assessment made by two independent 144 
researchers were first resolved by discussion, with the opinion of a third researcher sought if 145 
consensus was not reached. Reference lists of the final included studies were manually 146 
searched for any relevant articles not identified in the initial search. 147 
Critical Appraisal of Risk of Methodological Bias 148 
Critical appraisal of each individual study was carried out by two independent reviewers 149 
using a modified version of the Quality Index (24). Similar to previous systematic reviews, 150 
we elected to use an abridged version containing 16 items relevant to a range of study 151 
designs, whilst still being applicable to randomised studies. The 16 items assessed the 152 
reporting quality, external validity and internal validity (bias and confounding). Each study 153 
was scored with the tool with each item graded as Yes (1 point), No (0 points) or unable to 154 
determine (0 points) to give a total score out of 16. 155 
Data Extraction 156 
Point estimates of effects including descriptive (means, medians, standard deviations, change 157 
scores) and inferential statistical information (p-values, confidence intervals) were extracted 158 
and cross-checked by two reviewers (JA and DW). Where different wedge angulations were 159 
given between participants and raw data were available, the mean value was computed. When 160 
adequate data was reported, standardised mean differences were calculated as the mean 161 
difference in the biomechanical parameter between the insole and no-insole conditions, 162 
divided by the pooled standard deviation with adjustment for small sample sizes (Hedges g: 163 
SMD)(25). Where not reported, the standard error of the mean difference and correlations 164 
between outcomes were estimated from P-values using the equivalent T-statistic (26). When 165 
this was not possible, an imputation approach was taken where the standard error of the mean 166 
difference was estimated using the lowest correlation estimate from other studies (26). If 167 
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more information was required from that provided in the paper, authors were contacted 168 
directly to provide necessary data (relevant data from two studies was provided immediately). 169 
Data Synthesis and Analysis 170 
Meta-analysis was performed in Review Manager (RevMan) software (version 5.2, Cochrane 171 
Collaboration, Oxford, UK) using the inverse variance method, where the contribution of 172 
effect sizes from individual studies is weighted on sample size and their precision of the 173 
estimate. Significant heterogeneity across studies was anticipated due to differences in the 174 
distribution of participant characteristics (i.e. severity of OA), therefore a random-effects 175 
model was used to more conservatively estimate the pooled effect of the intervention. 176 
Sensitivity analysis according to the presence of a neutral (flat) insole was also performed 177 
when possible to assess the effect of this feature of study design to alter the biomechanical 178 
differences between conditions, as it has previously been shown to influence clinical 179 
outcomes (19). Publication bias was assessed using funnel plots and Egger’s regression test 180 
using STATA (v14, StataCorp, College Station, TX, USA). 181 
Statistical heterogeneity was assessed using the Chi2 test and Cochran’s Q statistic, which 182 
determines whether observed differences in results between studies differ due to chance 183 
alone, and the I2 statistic, which describes the percentage of the variability in effect estimates 184 
that is due to heterogeneity rather than sampling error (chance). Guidelines from the 185 
Cochrane Collaboration were followed for the interpretation of heterogeneity, where 25, 50 186 
and 75% represent low, moderate and high heterogeneity, respectively (27).  Effect sizes 187 
were interpreted as 0.2 (small), 0.5 (medium) and 0.8 (large) (28). To contextualise the effect 188 
sizes, the overall pooled estimates were back-transformed into original units using reference 189 
data from the largest study (15) (n=73) with mean and standard deviations of 3.82 SD 0.78 190 
(Nm/%BW*Ht) for the 1st peak EKAM and 1.26 SD 0.37 (Nm.s/BW*Ht) for the KAAI.  191 
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Results 192 
Three hundred and eighty three (383) records were identified. After assessing eligibility 193 
against the criteria, 48 studies were retained for full-text review. Eighteen studies met all 194 
eligibility criteria and were included in the final review (Figure 1). Eleven review articles 195 
were identified on the topic, but searching of reference lists yielded no additional studies not 196 
identified in the primary search. Authors of two studies provided additional data to allow 197 
effect sizes to be calculated (29, 30). 198 
                    ****Figure 1 here**** 199 
Study Characteristics 200 
The 18 eligible studies included a total of 534 participants. All but four studies were within-201 
subjects repeated measures designs, with the remaining being randomised trials (30-33). Four 202 
studies reported the use of the American College of Rheumatology (ACR) criteria (31, 34-203 
36), with ten stating cut-offs regarding the severity of knee pain (13, 21, 29, 31, 32, 34, 36-204 
39), most commonly >3/10 on a visual analog scale (21, 31, 32, 34, 37, 38, 40). This 205 
definition varied across studies according to the activity, with pain recalled during walking 206 
(29, 39), walking two blocks and/or climbing stairs (36), weight bearing activities (38) on 207 
most days of the past month (21, 32, 41). All studies included radiographic assessment of 208 
tibiofemoral OA. This was most commonly defined as Kellgren-Lawrence Grade 2 and above 209 
(21, 29, 31, 32, 34, 37-40, 42). Presence of medial joint space narrowing greater than lateral 210 
(13, 21, 29, 32, 33, 35, 36, 39, 41) and/or varus knee alignment (30, 36, 40, 42, 43) were used 211 
to limit participants to those with medial tibiofemoral OA. 212 
Two studies reported the effects of heel wedges (43, 44), 14 studies investigated full-length 213 
insoles and two studies included both heel and full-length insoles (40, 45).  The most 214 
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common insole inclination angle was five degrees (21, 29, 32, 33, 36, 39-41, 45), with insole 215 
angles ranging from four (42) to 11 degrees (34). The presence of a concomitant medial arch 216 
support was common with four studies modifying generic insoles(31, 37, 38, 45) and three 217 
used a bespoke design (29, 33, 39). Fourteen studies prescribed the same insole to all 218 
participants, with the remaining four using a customised amount based on comfort and/or 219 
pain level (31, 35, 37, 38). A flat insole was the comparison condition in four studies(31, 34, 220 
37, 38), seven studies used participants’ own footwear (21, 30, 32, 36, 40, 42, 45) , five 221 
studies used standardised footwear(29, 33, 35, 39, 44), one study used both a flat insole and 222 
participants own footwear (41) and one study did not report the type of footwear (43). 223 
Walking speed was either controlled across conditions within a threshold of each 224 
participants’ preferred speed(21, 31, 32, 36-38, 40), self-selected by participants but 225 
comparable across conditions (35, 41, 43), uncontrolled and not taken into account or 226 
reported(29, 30, 33, 34, 39, 42, 44) or the method was not reported but walking speed 227 
remained similar(45). Table 1 and Table 2 summarise the characteristics of included studies 228 
and participants. 229 
****Table 1 here****  230 
****Table 2 here****  231 
Knee joint loading 232 
1st peak external knee adduction moment (EKAM) 233 
Eighteen studies reported the effect of lateral wedge insoles on the 1st peak EKAM, of which 234 
13 used a shoe-only comparison and five used a neutral (flat) insole. As some studies made 235 
multiple comparisons with different insole angles, a total of 27 comparisons were included in 236 
the data synthesis (20 shoe comparison, seven neutral (flat) insole comparison) (Table 3). 237 
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The overall pooled effect estimate suggested that lateral wedge insoles resulted in a 238 
statistically significant reduction in the 1st peak EKAM (SMD = -0.19 [95% CI -0.23 − -239 
0.15], p <0.001), with a low level of statistical heterogeneity (Chi2 = 26.7, p = 0.42, I2 = 3%) 240 
(Figure 2). This represents a small effect size and equates to an absolute change in the 1st 241 
peak EKAM of approximately 0.15 %BW*Ht. Subgroup comparisons yielded similar results, 242 
with the pooled effect similar in both shoe-only (SMD= -0.20 [95% CI -0.25 − -0.14]) and 243 
neutral (flat) insole comparisons (SMD = -0.22 [95% CI -0.30 − -0.13]). Egger’s regression 244 
test for funnel plot asymmetry were not statistically significant, indicating weak evidence of 245 
publication bias for the 1st peak EKAM (β = -0.61, SE 0.37 p = 0.111) (Supplementary File 246 
2). 247 
****Figure 2 here****  248 
2nd peak external knee adduction moment (EKAM) 249 
Eight studies reported the effect of LWI on the 2nd peak EKAM; seven studies with a shoe-250 
only comparison, one study with a neutral (flat) insole comparison and one study reported 251 
both comparisons. A total of 12 comparisons were included in the data synthesis (Table 3). 252 
Overall, LWI resulted in a statistically significant reduction in the 2nd peak EKAM (SMD = -253 
0.25 [95% CI -0.31 − -0.18], p <0.001), with a low to medium level of statistical 254 
heterogeneity (Chi2 = 14.8, p = 0.19, I2 = 26%) (Figure 3). 255 
There was also evidence for differences according to subgroup analysis, with comparisons 256 
relative to shoe-only conditions resulting in a larger pooled effect (SMD = -0.29 [95% CI -257 
0.35 − -0.22]) than neutral (flat) insole comparisons (SMD = -0.15 [95% CI -0.24 − -0.06]). 258 
Egger’s regression test for funnel plot asymmetry were not statistically significant, indicating 259 
weak evidence of publication bias for the 2nd peak EKAM (β = -0.29, SE 1.27 p = 0.822).    260 
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****Figure 3 here****  261 
Knee adduction angular impulse (KAAI) 262 
Nine studies with a total of 11 comparisons were reported for the effect of LWI on the KAAI, 263 
with all but one comparing the LWI to a shoe-only condition (Table 3). The overall pooled 264 
estimate indicated a statistically significant reduction in the KAAI with LWI (SMD = -0.14 265 
[95% CI -0.21 − -0.07], p <0.001), with a low level of statistical heterogeneity (Chi2 = 14.44, 266 
p = 0.15, I2 = 31%) (Figure 3). The pooled effect size equates to an absolute change in the 267 
KAAI of approximately 0.05 Nm.s/BW*Ht. Egger’s regression test for funnel plot 268 
asymmetry were not statistically significant, indicating weak evidence of publication bias for 269 
the KAAI (β = -0.53, SE 1.19 p = 0.663). 270 
****Figure 4 here****  271 
****Table 3 here****  272 
Risk of Bias 273 
The modified index scores of included publications ranged from eight to 13 out of 16 (Table 274 
1). Scoring agreement from two reviewers was evident on 271 of 288 items (agreement = 275 
94%). Less than half of studies satisfactorily described their employed intervention clearly 276 
(item 4) with most neglecting to report the density of the insole material. Inadequate 277 
reporting of sampling methods for recruitment (item 8) and reporting of the proportion of 278 
participants who agreed to participate from the initial recruitment (item 9) was also common. 279 
All studies also failed to report if they blinded the assessors during the analysis of primary 280 
outcome measures (item 11). Full risk of bias scoring is provided in Supplementary File 3. 281 
        282 
Discussion 283 
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This meta-analysis has demonstrated that lateral wedge insoles cause small reductions on 284 
biomechanical risk factors for disease progression (EKAM and KAAI) in people with medial 285 
knee OA. Proxies for medial relative to lateral compartment load were reduced with the use 286 
of lateral wedge insoles, including the 1st peak EKAM, 2nd peak EKAM and KAAI, 287 
irrespective of the presence of a neutral insole or footwear comparison. 288 
This is the first meta-analysis on the effect of lateral wedge insoles on parameters of medial 289 
knee joint load (EKAM and KAAI) relevant to disease progression in people with knee OA. 290 
One previous review attempted to perform quantitative comparisons but did not establish 291 
pooled effect estimates (46). This review is therefore the most definitive, up-to-date and 292 
comprehensive analysis on this issue to clarify the effects of lateral wedge insoles on 293 
biomechanical risk factors for knee OA progression. 294 
Lateral wedge insoles were associated with a modest reduction in the EKAM, questioning 295 
their potential to attenuate structural changes considering the effect of elevated knee load on 296 
risk for disease progression. A meta-analysis of prospective studies reported 1.9 times 297 
increased odds of OA progression for every 1 unit increase in the peak EKAM (%BW*Ht) 298 
(47). The overall effects revealed in this review on the 1st peak EKAM equates to a minimal 299 
reduction of 0.15 %BW*Ht. This may, in part, may explain the findings from randomised 300 
trials that lateral wedge insoles did not reduce the rate of cartilage loss over 12 months (48) 301 
or the rate of joint space narrowing over 2 years (49). Conversely, an alternate explanation is 302 
the inclusion of all participants with knee OA in previous clinical trials, despite up to 23% 303 
showing paradoxical increases in medial knee joint load with the use of lateral wedge insoles 304 
(29, 32). Recent evidence indicates that individuals with greater eversion of the ankle/subtalar 305 
complex during walking are more likely to decrease their EKAM when using a lateral wedge 306 
insole (50). Prescription based on biomechanical response and use of insoles only in 307 
individuals who show reductions in knee joint loading (biomechanical phenotypes) appears 308 
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more appropriate to increase the likelihood of a favourable long-term response regarding the 309 
attenuation of structural changes. This would limit their application and benefit to a smaller 310 
number of individuals, but is still likely to be significant considering the overall prevalence of 311 
knee OA and projected rise due to population ageing and rising obesity levels (51). Further 312 
research investigating targeted use of lateral wedge insoles in biomechanical phenotypes 313 
likely to benefit is required to fully interrogate their potential to limit disease progression. 314 
An important issue regarding knee load exposure in osteoarthritis is the concept of 315 
cumulative loading (52). Despite associations between the EKAM and disease progression, 316 
the KAAI has been proposed as a more useful measure to account for both the duration and 317 
magnitude of loading in knee OA. Indeed, the KAAI but not the peak EKAM has been 318 
associated with medial tibiofemoral cartilage loss over 12 months (6) and 2 years (11). 319 
Although the overall reduction in the peak EKAM and KAAI with lateral wedge insoles per 320 
step was small, it may surmount to a large cumulative effect imparted on the knee over the 321 
course of the day (52). This should be considered when interpreting the findings of this 322 
review and future research on load modifying interventions in knee osteoarthritis. 323 
Unlike the results of a meta-analysis on the effect of lateral wedge insoles on pain (19), no 324 
subgroup differences according to use of a neutral (flat) insole were observed for the 1st peak 325 
EKAM. A subgroup difference was observed for the 2nd peak EKAM, with studies without a 326 
neutral insole comparison reporting smaller effect sizes. This is inconsistent with concern that 327 
flat insoles are not biomechanically inert, and considering the results of this meta-analysis 328 
and others (19), appears more relevant to the placebo effect and pain outcomes rather than 329 
knee loading. 330 
The main limitation to this review was the available body of evidence, which primarily 331 
consisted of peer-reviewed single-group crossover studies testing the immediate effect of 332 
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insoles. Numerous RCTs on lateral wedge insoles have been published, but report only pain 333 
outcomes (19) and data on their acquired or long term biomechanical effects are scarce (31).  334 
We assessed for the presence of publication bias by using funnel plots and formal testing 335 
which revealed weak evidence for an effect, strengthening the inferences from this review. 336 
An imputation approach for some comparisons was used to derive standard errors for effect 337 
sizes, however we took the most conservative approach by using the lowest correlation 338 
estimate amongst studies with all available data (26). The variability in measurement 339 
approach for the EKAM is also worthy of mention, however given the relative consistency in 340 
findings across studies this appears to have not had a major influence. The use of the EKAM 341 
to infer knee load in previous studies is also contentious as the contribution of muscle forces 342 
to joint load is not considered. However, clinical relevance was maintained in this review by 343 
the focus on outcomes that have demonstrated links with disease progression (3, 6).  344 
In conclusion, lateral wedge insoles have a small effect on reducing medial knee joint load in 345 
people with medial knee OA. The magnitude of the changes observed in the EKAM and 346 
KAAI equates to minimal absolute reduction in knee joint load. At present, lateral wedge 347 
insoles appear ineffective at attenuating structural changes in people with medial knee OA as 348 
a whole. Recent evidence suggests they may be better suited to targeted use in biomechanical 349 
phenotypes associated with larger reductions in knee load, with future clinical trials required 350 
to investigate this potential. 351 
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Table 1. Characteristics of included studies and intervention 
 
 
Authors Country Clinical criteria Intervention Comparisons Applied QI Score 
(/16) 
Abdallah et al. 
(2011) (34) 
Egypt ACR criteria 
Pain VAS (≥30 mm) 
 
6° and 11° full length lateral 
wedge insoles with medial arch 
supports 
Neutral insole Bilateral  8 
Barrios et al. 
(2013)  (31) 
United 
States 
ACR criteriaa 
Pain VAS (≥3/10) 
8° full length lateral wedge 
insoles (customised via 
subjective comfort)  and adhered 
to off the shelf insoles  
Neutral insole Unilateral 13 
Butler et al. 
(2007) (37) 
United 
States 
Pain VAS (≥3/10) 9° full length lateral wedge 
insoles (customised via 
subjective comfort)  and adhered 
to off the shelf insoles adhered to 
the neutral orthoses 
Neutral insole Unilateral 7 
Butler et al. 
(2009) (38) 
United 
States 
Pain VAS (≥3/10) 
during weight bearing 
activities 
10° full length lateral wedge 
insoles (customised via 
subjective comfort)  and adhered 
to off the shelf insoles 
Neutral insole Unclear 9 
Duivenvoorden 
et al.  
(2015) (30) 
 
The 
Netherlands 
Pain VAS (/10) mean: 
6 SD 3, WOMAC 
(/100) mean: 47 SD 
19 
6° full length lateral wedged 
insole 
Own shoes Unclear 9 
Hinman et al. 
(2012) (32) 
Australia Pain VAS (>3/10 
upon walking) & on 
most days of past 
month 
WOMAC pain (/20) 
mean: 7 SD 3; 
function (/68) mean: 
25 SD 13 
5° full length non customised 
standard lateral wedged insoles  
Own shoes Bilateral 12 
Hinman et al. 
(2009) (21) 
Australia Pain VAS (>3/10 
upon walking) & on 
most days of past 
month 
WOMAC pain (/20) 
mean: 6 SD 3; 
function (/68) mean: 
20 SD 14 
5° full length non customised 
lateral wedged insoles 
Own shoes Bilateral 11 
Hinman et al. 
(2008a) (13) 
Australia Pain VAS (>3/10 
upon walking) & on 
most days of past 
month 
WOMAC pain (/20) 
mean: 8 SD 3; mean 
stiffness: 4 SD 2; 
function (/68) mean: 
24 SD 11 
5° full length and rearfoot lateral 
wedged insoles 
Own shoes Bilateral 9 
Hinman et al. 
(2008b) (36) 
Australia Pain Likert-type scale 
average (>3/11), on 
most days of previous 
month and when 
walking 2 blocks 
and/or climbing stairs 
WOMAC pain (/20) 
mean: 9 SD 3; 
function (/68) mean: 
30 SD 11 
5° full length non customised 
standard lateral wedged insoles 
Own shoes Bilateral 10 
Jones et al. 
(2013a) (39) 
United 
Kingdom 
Mild pain walking on 
flat surface during the 
past week (in KOOS 
pain subscale) 
5° full length lateral wedged 
insoles; one with medial arch 
support, one without 
Standardised 
shoe 
Bilateral 9 
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Authors Country Clinical criteria Intervention Comparisons Applied QI Score
(/16) 
Jones et al. 
(2013b) (33) 
United 
Kingdom 
Symptomatic medial 
compartment OA 
confirmed by surgeon 
and x-rays. WOMAC 
pain (/100) mean 50 
SD 15.7; stiffness 
(/100) mean 61.5 SD 
20.3; function (/100) 
mean 54.2 SD 13.9 
5° full length lateral wedged 
insoles with medial arch support 
Standardised 
shoe 
Bilateral 10 
Jones et al. 
(2014) (29) 
United 
Kingdom 
Mild pain walking on 
flat surface during the 
past week (in KOOS 
pain subscale) 
5° full length lateral wedged 
insoles; one with medial arch 
support, one without 
Standardised 
shoe 
Bilateral 10 
Kerrigan et al. 
(2002) (41) 
United 
States 
Knee pain on most 
days of recent month 
5° and 10° full length lateral 
wedged insoles  
Flat insole + 
own shoes 
Unclear 9 
Leitch et al. 
(2011) (44) 
Canada Clinical diagnosis of 
OA confined primarily 
to medial tibiofemoral 
compartment 
4° and 8° heel wedge placed 
underneath the insole on the 
lateral side of the shoe 
Standardised 
shoe 
Unilateral 10 
Maly et al. 
(2002) (45) 
United 
States 
Medial compartment 
OA confirmed by 
physician and x-rays. 
WOMAC total (/96): 
38 SD 14; mean pain 
(/20): 7 SD 3; mean 
stiffness (/8): 3 SD 1; 
mean function (/68): 
26 SD 10 
5° valgus heel wedge (modified 
off-the-shelf orthosis) 
Routine 
footwear 
Bilateral 8 
Moyer et al. 
(2013) (35) 
Canada ACR criteria 
Symptoms at medial 
TFJ 
KOOS mean pain: 
49.3 SD 15.9; mean 
symptoms: 37.5 SD 
11.2; mean ADL: 54.3 
SD 15.3; mean sport 
& rec: 18.8 SD 14; 
mean KOOS QoL: 
23.8 SD 13.7 
3°, 6° and 9° full length lateral 
wedge insole (customised via 
subjective comfort) 
Standardised 
shoes 
Unilateral 9 
Pagani et al. 
(2012) (42) 
Germany WOMAC  
(11pt scale) mean 
pain: 9.8 SD 3.7 
mean stiffness: 7.8 
SD 2.8 
4° full length lateral wedged 
insole 
Own shoes Bilateral 9 
Shimada et al. 
(2006) (43) 
Japan Not reported 6° heel wedge (10 mm height) Not reported Bilateral 8 
 
a stated inclusion criteria were consistent with ACR criteria, but all criteria not reported as assessed 
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Table 2. Characteristics of participants in included studies 
Authors n Gender  
(M:F) 
Age  
(years)  
 
Height  
(m) 
 
Body 
mass 
(kg) 
 
BMI 
(kg/m2) 
Bilateral 
knee OA 
included 
Radiographic 
features 
KL Grade 
1 2 3 4 
Abdallah et al. (2011) 
(34) 
21 
 
0:21 54.1 
(7.4) 
1.57 
(0.06) 
84.1 
(8.7) 
NR NR KL Grade ≥2 
FTA: 176 - 
180°(varus) 
NR NR NR NR 
Barrios et al. (2013)  
(31) 
38
a 
 
NR 62.6 
(7.4) 
NR NR 33.6 
(7.6) 
Yes KL Grade ≥2  
medial tibiofemoral 
compartment 
0 8 6 5 
Butler et al. (2007) 
(37) 
20 9:11 63 (6) NR NR 33.4 
(7.8) 
Yes KL Grade ≥2  
medial tibiofemoral 
compartment 
0 7 6 7 
Butler et al. (2009) 
(38) 
30 13:17 63.1 
(6.8) 
NR NR 33.8 
(6.9) 
NR KL Grade ≥2  
medial tibiofemoral 
compartment  
0 9 9 11 
Duivenvoorden et al.  
(2015) (30) 
 
42 
 
14:28 54 (7) NR NR 30 (5) NR KL Grade ≥1 
Hip-Knee-Ankle 
angle (°varus): 7 
SD 4 
15 8 18 1 
Hinman et al. (2012)  
(32) 
73 28:45 63.3 
(8.4) 
1.67 
(0.09) 
77.2 
(14.5) 
27.7 
(3.6) 
Yes Medial tibiofemoral 
osteophytes & JSN 
medial > lateral  
KL Grade 2 & 3 
Mechanical axis: 
180.9° SD 2.6 
(0.9°valgus) 
0 41 32 0 
Hinman et al. (2009) 
(21) 
20 8:12 63.5 
(9.4) 
1.69 
(0.07) 
83.1 
(14.2) 
NR Yes Medial tibiofemoral 
osteophytes & JSN 
medial > lateral; 
KL Grade 2 & 3 
0 8 12 0 
Hinman et al. (2008a) 
(13) 
13 6:7 59.7 
(6.2) 
1.69 
(0.14) 
81.0 
(20.4) 
NR Yes Medial tibiofemoral 
osteophytes 
KL Grade 2 & 3 
Mechanical axis: 
(°): 178.1 SD 2.9 
(1.9° varus)b 
0 7 6 0 
Hinman et al. (2008b) 
(36) 
40 16:24 64.7 
(9.4) 
1.64 
(0.09) 
79 
(12) 
29.6 
(4.2) 
Yes Medial tibiofemoral 
osteophytes 
Mechanical axis: 
174.5 SD 4.7 
(5.5°varus) 
3 10 11 16 
Jones et al. (2013a) 
(39) 
51 29:22 59.6 
(8.9) 
1.69 
(0.08) 
90.3 
(17.9) 
31.6 
(5.07) 
Yes KL grade 2 or 3 
& JSN medial > 
lateral; no 
tricompartment OA 
0 22 29 0 
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Authors [reference] n Gender  
(M:F) 
Age  
(years)  
 
Height 
(m) 
 
Body 
mass 
(kg) 
 
BMI 
(kg/m2) 
Bilateral 
knee OA 
included 
Radiographic 
features 
KL Grade (n=)
1 2 3 4 
Jones et al. (2013b) 
(33) 
28 16:10 66.3 
(8.2) 
1.75 
(0.13) 
88.7 
(15.1) 
NR NR Medial JSN; no 
lateral or PFJ 
OA 
0 10 18 0 
Jones et al. (2014) 
(29) 
70 43:27 60.3 
(9.6) 
1.69 
(0.09) 
87.3 
(18.5) 
30.5 
(4.9) 
NR KL grade 2 or 
3 
& JSN medial 
> lateral 
compartment, 
no tibiofemoral 
+ PFJ OA 
0 17 25 0 
Kerrigan et al. (2002) 
(41) 
15 8:7 69.7 
(7.6) 
1.67 
(0.07) 
83.9 
(11.9) 
NR NR KL Grade  ≥3 
Presence of 
definite 
osteophyte & 
medial JSN 
(but not lateral) 
0 0 10 5 
Leitch et al. (2011) 
(44) 
12 5:7 48 (9) 1.72 
(0.11) 
90.5 
(16.8) 
30.45 
(4.22) 
NR All KL Grades 
 
2 2 3 5 
Maly et al. (2002) 
(45) 
12 9:3 60 
(9.39) 
NR 99.1 
(15.8) 
32.42 
(5.03) 
NR NR 
 
 
NR NR NR NR 
Moyer et al. (2013) 
(35) 
16 8:8 55 (7.0) NR NR 32 (6.2) No KL Grade ≥1 & 
JSN medial > 
lateral 
Mechanical 
axis: 173.4° 
(6.6° varus)  
2 5 6 3 
Pagani et al. (2012) 
(42) 
10 2:8 57.5 
(7.1) 
1.68 
(0.04) 
78.8 
(12.2) 
28 (4.3) NR KL Grade ≥2 
Mean varus 
malalignment 
(°varus): 2.1 
SD 1.2c 
0 6 4 0 
Shimada et al. (2006) 
(43) 
23 6:17 67.0 
(8.7) 
1.50 
(0.07) 
60.3 
(7.1) 
NR Yes KL Grade ≥1 
Mechanical 
axis:  
6.2° varus SD 
4.4 
11 11 13 11 
 
All values are reported as mean (standard deviation) unless otherwise indicated 
a total sample size was 38 but 19 allocated to insole group 
b FTA angle computed from A-P knee x-ray and regression equation 
c hip-knee-ankle angle estimated from motion capture data 
NR: not reported; PFJ: patellofemoral joint; QI: Downs & Black Quality Index 
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Table 3. Summary of comparisons across 18 studies included in the analysis of the 1st peak external knee adduction moment (EKAM), 2nd peak 
EKAM and knee adduction angular impulse (KAAI) 
 
Authors Information available Unit of 
measure 
Study comparisons SMD (A-B) SE (A-B) Correlation 
used 
   Condition (A) Comparator (B)    
 
1st peak knee adduction moment (EKAM) 
 
      
Abdallah et al. 2011 
 
Treatment specific summaries, 
correlation assumed 
Nm/kg 6° full length wedged insole Flat insole -0.18 0.17 0.70 
Abdallah et al. 2011b 
 
Treatment specific summaries, 
correlation assumed 
Nm/kg 11° full length wedged insole Flat insole -0.31 0.17 0.70 
Barrios et al. 2013 Treatment specific summaries, 
correlation assumed 
Nm/kg m 8° full length wedged insolea  
 
Flat insole -0.19 0.18 0.70 
Butler et al. 2007 
 
Treatment specific summaries,  
P values (t-test) 
Nm/kg*m 9° full length wedged insole Flat insole -0.25 0.09 0.92 
Butler et al. 2009 
 
Treatment specific summaries,  
P values (t-test) 
Nm/kg*m 10° full length wedged insole Flat insole -0.24 0.09 0.88 
Duivenvoorden et al. 2015 Treatment specific summaries, 
correlation assumed 
NR 6° full length wedged insole Participant’s own shoes -0.10 0.13 0.70 
Hinman et al. 2008a 
 
Treatment specific summaries,  
P values (t-test) 
%BW*Ht 5° full length wedged insole Participant’s own shoes -0.53 0.23 0.72 
Hinman et al. 2008b 
 
Treatment specific summaries,  
P values (t-test) 
%BW*Ht 5° heel wedge Participant’s own shoes -0.32 0.23 0.70 
Hinman et al. 2008c 
 
Treatment specific summaries, 
correlation assumed 
%BW*Ht 5° full length wedged insole Participant’s own shoes -0.21 0.12 0.70 
Hinman et al. 2009 
 
Treatment specific summaries, 
correlation assumed 
%BW*Ht 5° full length wedged insole Participant’s own shoes -0.32 0.17 0.70 
Hinman et al. 2012 
 
Treatment specific summaries,  
P values (t-test) 
%BW*Ht 5° full length wedged insole Participant’s own shoes -0.28 0.08 0.74 
Jones et al. 2013a 
 
Treatment specific summaries, 
correlation assumed 
Nm/kg 5° full length wedged insole Standardised shoe† -0.14 0.11 0.70 
Jones et al. 2013b 
 
Treatment specific summaries, 
correlation assumed 
Nm/kg 5° full length wedged insole a  Standardised shoe† -0.14 0.11 0.70 
Jones et al. 2013c 
 
Treatment specific summaries,  
P values (t-test) 
Nm/kg 5° full length wedged insole a Standardised shoe† -0.54 0.15 0.70 
Jones et al. 2014 
 
Group differences,  
correlation assumed 
Nm/kg 5° full length wedged insole Standardised shoe† -0.14 0.04 d 0.95e
Jones et al. 2014b Group differences,  
correlation assumed 
Nm/kg 5° full length wedged insole a  Standardised shoe† -0.27 0.08 d 0.94e
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Kerrigan et al. 2002 
 
Treatment specific summaries,  
P values (t-test) 
N.m/kg.m 5° full length wedged insole Participant’s own shoes -0.22 0.08 0.96 
Kerrigan et al. 2002b 
 
Treatment specific summaries,  
P values (t-test) 
N.m/kg.m 5° full length wedged insole Flat insole -0.16 0.08 0.96 
Kerrigan et al. 2002c 
 
Treatment specific summaries,  
P values (t-test) 
N.m/kg.m 10° full length wedged insole Participant’s own shoes -0.37 0.10 0.93 
Kerrigan et al. 2002d 
 
Treatment specific summaries, 
correlation assumed 
N.m/kg.m 10° full length wedged insole Flat insole -0.30  0.20 0.70 
Leitch et al. 2011 
 
Treatment specific summaries, 
correlation assumed 
%BW*Ht 4° heel wedge Standardised shoe* -0.05 c 0.22 0.70
Leitch et al. 2011b 
 
Treatment specific summaries, 
correlation assumed 
%BW*Ht 8° heel wedge Standardised shoe* -0.10 c 0.22 0.70
Maly et al. 2002 
 
Treatment specific summaries, 
correlation assumed 
Nm/kg 5° full length wedged insole a  
 
Routine footwear  0.15 0.26 0.70 
Maly et al. 2002b 
 
Treatment specific summaries,  
P values (F-test) 
Nm/kg 5° heel wedge Routine footwear -0.07 0.05 0.99 
Moyer et al. 2013 
 
Treatment specific summaries, 
correlation assumed 
%BW*Ht 4° full length wedged insole a  
 
Standardised shoe^ -0.09 0.19 0.70 
Pagani et al. 2012 
 
Treatment specific summaries, 
correlation assumed 
Nm/kg 4° full length wedged insole Participant’s own shoes -0.19 0.25 0.70 
Shimada et al. 2006 
 
Treatment specific summaries,  
P values (t-test) 
 
Nm/kg   6° heel wedgeb NR (footwear assumed) -0.20 0.05 0.97 
2nd peak knee adduction moment (EKAM) 
 
      
Butler et al. 2007 
 
Treatment specific summaries,  
P values (t-test) 
Nm/kg*m 9° full length wedged insole Flat insole -0.06 0.11 0.89 
Hinman et al. 2008a 
 
Treatment specific summaries,  
P values (t-test) 
%BW*Ht 5° full length wedged insole Participant’s own shoes -0.33 0.12 0.92 
Hinman et al. 2008b 
 
Treatment specific summaries,  
P values (t-test) 
%BW*Ht 5° heel wedge Participant’s own shoes -0.16 0.11 0.93 
Hinman et al. 2008c 
 
Treatment specific summaries, 
correlation assumed 
%BW*Ht 5° full length wedged insole Participant’s own shoes -0.31 0.07 0.89 
Hinman et al. 2009 
 
Treatment specific summaries, 
correlation assumed 
%BW*Ht 5° full length wedged insole Participant’s own shoes -0.15 0.11 0.89 
Jones et al. 2013c 
 
Treatment specific summaries,  
P values (t-test) 
Nm/kg 5° full length wedged insole a Standardised shoe† -0.49 0.10 0.89 
Kerrigan et al. 2002 
 
Treatment specific summaries,  
P values (t-test) 
N.m/kg.m 5° full length wedged insole Participant’s own shoes -0.27 0.07 0.96 
Kerrigan et al. 2002b 
 
Treatment specific summaries,  
P values (t-test) 
N.m/kg.m 5° full length wedged insole Flat insole -0.16 0.06 0.97 
Kerrigan et al. 2002c 
 
Treatment specific summaries,  
P values (t-test) 
N.m/kg.m 10° full length wedged insole Participant’s own shoes -0.32 0.08 0.95 
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Kerrigan et al. 2002d 
 
Treatment specific summaries, 
correlation assumed 
N.m/kg.m 10° full length wedged insole Flat insole -0.22 0.12 0.89 
Moyer et al. 2013 
 
Treatment specific summaries, 
correlation assumed 
%BW*Ht 4° full length wedged insole a Standardised shoe^ -0.22 0.13 0.89 
Pagani et al. 2012 
 
Treatment specific summaries, 
correlation assumed 
 
Nm/kg 4° full length wedged insole Participant’s own shoes -0.17 0.15 0.89 
Knee adduction angular impulse (KAAI) 
 
      
Barrios et al 2013 Treatment specific summaries, 
correlation assumed 
Nm.s.kg.m 8° full length wedged insole Insole comparison -0.01 0.09 0.68 
Duivenvoorden et al. 2015 Treatment specific summaries, 
correlation assumed 
NR 6° full length wedged insole Participant’s own shoes -0.02 0.09 0.68 
Hinman et al. 2009 
 
Treatment specific summaries, 
correlation assumed 
%BW*Ht 5° full length wedged insole Participant’s own shoes -0.14 0.18 0.68 
Hinman et al. 2012 
 
Treatment specific summaries, 
P values (t-test) 
%BW*Ht 5° full length wedged insole Participant’s own shoes -0.21 0.06 0.86 
Jones et al. 2013a 
 
Treatment specific summaries, 
correlation assumed 
Nm/kg 5° full length wedged insole Standardised shoe† -0.16 0.09 0.68 
Jones et al. 2013b 
 
Treatment specific summaries, 
correlation assumed 
Nm/kg 5° full length wedged insole a Standardised shoe† -0.16 0.09 0.68 
Jones et al. 2013c 
 
Treatment specific summaries, 
P values (t-test) 
Nm/kg 5° full length wedged insole a Standardised shoe† -0.57 0.16 0.68 
Jones et al. 2014 
 
Group differences,  
correlation assumed 
Nm/kg 5° full length wedged insole Standardised shoe† -0.17 0.09d 0.74e
Jones et al. 2014b 
 
Group differences,  
correlation assumed 
Nm/kg 5° full length wedged insole a Standardised shoe† -0.13 0.09d 0.72e
Moyer et al. 2013 
 
Treatment specific summaries, 
correlation assumed 
%BW*Ht 4° full length wedged insole a  Standardised shoe^ -0.02 0.09 0.68 
Pagani et al. 2012 
 
Treatment specific summaries, 
correlation assumed 
Nm/kg 4° full length wedged insole Participant’s own shoes -0.14 0.25 0.68 
 
a with medial arch support 
b 10 mm height equates to 6 degree angulation as reported in Duivenvoorden et al (2015) 
c values obtained from figures 
d pooled standard deviation computed from SD of difference scores as raw values not reported 
e correlation computed taking into account comparator standard deviation only as intervention not reported 
†Ecco – Zen, Bredebro, Denmark 
^ New Balance, Boston, MA, USA; *New Balance 882, Boston, MA, USA; NR: not reported 
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Figure legends 
Figure 1: PRISMA flowchart of study selection.  
Figure 2: Forest plot of data pooling for the 1st peak external knee adduction moment 
(EKAM). Solid squares indicate the effect size and horizontal bars the 95% confidence 
interval (95% CI). Solid diamonds represent the pooled estimate. Included studies were 
weighted based on the standard error of the effect size. 
Figure 3: Forest plot of data pooling for the 2nd peak external knee adduction moment 
(EKAM) and knee adduction angular impulse (KAAI). Solid squares indicate the effect size 
and horizontal bars the 95% confidence interval (95% CI). Solid diamonds represent the 
pooled estimate. Included studies were weighted based on the standard error of the effect 
size. 
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Figure 1. PRISMA flowchart of study selection.  
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Figure 2. Forest plot of data pooling for the 1st peak external knee adduction moment 
(EKAM). Solid squares indicate the effect size and horizontal bars the 95% confidence 
interval (95% CI). Solid diamond represents the pooled estimate. Included studies were 
weighted based on the standard error of the effect size. 
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Figure 3. Forest plot of data pooling for the 2nd peak external knee adduction moment 
(EKAM) and knee adduction angular impulse (KAAI). Solid squares indicate the effect size 
and horizontal bars the 95% confidence interval (95% CI). Solid diamond represents the 
pooled estimate. Included studies were weighted based on the standard error of the effect 
size. 
 
 
 
 
